A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

Clinical trial NCT01166490 · COMPLETED

Trial details

NCT number: NCT01166490
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Neoplasms Pancreatic Neoplasms

Start date: 2010-07-01
Primary completion: 2013-07-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.